Winner Profile
Baoguo Zhu
CEO, Livzon Pharmaceutical Group
Industry: Pharmaceuticals
Company size: Large
Published: 2017-12-08
Is Livzon Pharmaceutical Group a good stock investment?
Based on the annual Obermatt CEO of the Year analysis, Baoguo Zhu (Livzon Pharmaceutical Group) earned the following Obermatt pins for the management performance.
Obermatt accolades Baoguo Zhu
| Year | Pin | Category |
|---|---|---|
| 2017 |  |
Investment Performance |
 |
Combined Performance | |
|
Operating Performance | |
|
Growth Performance |
Baoguo Zhu was included in the competition among China Top 100 Growth Companies (China) (current winners). See the winners of the other competitions or how the CEOs performed over all competitions.
Performance Overview Baoguo Zhu
In summary, Baoguo Zhu obtained the following achievements in the individual Obermatt categories by participating in the Obermatt rankings (averages of all evaluated rankings are shown for this CEO, also for other companies):
CEO performance is displayed relative to that of other CEOs that competed in the same categories for the same number of competitions. A ranking of 68 in Combined Performance indicates that Baoguo Zhu was better than 68% of all other CEOs that were analyzed as part of the China Top 100 Growth Companies – China for one participation in Obermatt CEO competitions. Baoguo Zhu’s average ranking can be found in the Multi-Year Rankings for China Top 100 Growth Companies - China.